Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
405
-
Total 13F shares, excl. options
-
34.9M
-
Shares change
-
-121K
-
Total reported value, excl. options
-
$8.66B
-
Value change
-
-$30.6M
-
Put/Call ratio
-
1.11
-
Number of buys
-
196
-
Number of sells
-
-165
-
Price
-
$247.73
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q3 2020
450 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q3 2020.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 405 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.9M shares
of 152M outstanding shares and own 22.95% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.67M shares), VANGUARD GROUP INC (3.52M shares), BROWN CAPITAL MANAGEMENT LLC (1.53M shares), BAMCO INC /NY/ (1.5M shares), Jackson Square Partners, LLC (987K shares), Champlain Investment Partners, LLC (932K shares), DF DENT & CO INC (899K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (883K shares), STATE STREET CORP (883K shares), and ATLANTA CAPITAL MANAGEMENT CO L L C (879K shares).
This table shows the top 405 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.